Cargando…
Future Directions in Cardiac Amyloidosis
Just a few years ago, cardiac amyloidosis (CA) was rarely diagnosed. With poor treatment options and delayed and infrequent diagnoses, most patients who were eventually recognized to have CA were referred for hospice care. Now, the availability of sponsored genetic testing, increased use of nuclear...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932374/ https://www.ncbi.nlm.nih.gov/pubmed/35414857 http://dx.doi.org/10.14797/mdcvj.1071 |